Latest filing published 19 Dec 2012 for AtriCure, Inc., €50k.
First 200 filings with a declared amount
No signal scores available.
Based on 75 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Discovery Group I, LLC has filed trades across 8 companies (mainly through SEC (Form 4)), most often in Tessco Technologies Inc, National Medical Health Card Systems Inc and AtriCure, Inc. Over a trading history stretching from 10 February 2006 to 17 December 2012, the count stands at 624 filings.
On the open market, the record shows 363 purchases worth €13.9M and 261 sales worth €27.0M. The net balance comes to €13.1M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2012: 2 purchases and 107 sales on the market.
In size, the median ticket on the buying side is €12k. Looking at 75 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +34.9%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 19 December 2012, the filings show an open-market sale worth €50k in AtriCure, Inc. The last purchase on record was published on 7 September 2012, which is 5,160 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 614 declarations